Female Pelvic Medicine and Reconstructive Surgery
Q3IF1.4SJR0.650
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2023 | 1.4 | Q3 | 45.3% | — | — | |
| 2022 | 1.6 | Q4 | 46.3% | 0.650 | Q2 | 74.5% |
| 2021 | 1.9 | Q4 | 59.0% | 0.635 | Q2 | 74.6% |
| 2020 | — | — | 0.648 | Q2 | 74.0% | |
| 2019 | — | — | 0.661 | Q2 | 75.4% | |
| 2018 | — | — | 0.561 | Q2 | 68.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2151-8378
ISSN
2154-4212
country
UScoverage
2010-2022